RBC Capital analyst Luca Issi upgraded Regenxbio to Outperform from Sector Perform with a price target of $35, up from $20.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RGNX:
